- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
2023 PBMI Annual National Conference Starts Today
The keynote speaker for the three-day meeting in Orlando is Sampson Davis, M.D., an emergency medicine physician in New Jersey, an inspirational speaker and co-author of three best-selling books.
Federal legislation affecting pharmacy benefit managers (PBM), specialty pharmacy trends, biosimilars, cellular and gene therapy and health plan perspectives on PBMs are among the topics that will be featured at the Pharmacy Benefit Management Institute Annual National Conference that starts today in Orlando.
The keynote speaker for the three-day meeting is Sampson Davis, M.D., an emergency medicine physician in New Jersey, an inspirational speaker and co-author of three best-selling books. His inspiring story of growing up in Newark, N.J., and excelling academically and as a physician has attracted national attention. He has appeared on many television shows, including “Oprah,” “The Today Show” and “The View.”
Davis
Other featured speakers at the meeting include Doug Long, vice president of industry relations at IQVIA; Mike Baldzicki, chief commercial officer, Premier Pharmacy Services; Corey Coleman, vice president of health equity and strategic partnerships at Optum; Ann O’Brien, vice president of consultant relations at Prime Therapeutics; Jennifer Bartley, Pharm.D., M.S., MBA, director, product and innovation, at CVS Health; and Ellen Feeney, Pharm.D., director clinical pharmacy strategies at Highmark.
The meeting attracts attendees from payer and provider sectors, as well as executives and managers at PBMs. Managed Healthcare Executive is the official publication for the meeting.
In addition to Davis’ keynote, the sessions today include discussions of trends and opportunities in care management and an update on legislative and regulatory actions affecting PBMs.
Tomorrow starts with a session on PBMs and health plans on advancing health equity that Coleman is participating in. Other topics on the agenda include nonprescription digital therapeutics, medication adherence, and the ultra-rare orphan drug market.
Biosimilars, chronic disease, gene therapies and oncology specialty drug management are among the topics that Friday’s sessions will cover.
Michael Thompson on Employer-PBM Relations and What It Will Take to Change Them
September 12th 2023Thompson, the president of the National Alliance of Healthcare Purchaser Coalitions, said if that 20% of the market changes way it deals with PBMs “it will change the market, it will change the conversation, it will change the practices of key players.”
Read More
Patient, Provider Support is Key for Biosimilar Adoption| 2023 PBM I Annual National Conference
September 8th 2023There is a huge opportunity for savings from the recently launched Humira biosimilars and others expected to reach the market in the next few years. But plans and PBMs will need to step into the role that pharmaceutical manufacturers once did in supporting patients and prescribers.
Read More
